338 related articles for article (PubMed ID: 17629653)
1. Structural identification and characterization of potential impurities of pantoprazole sodium.
Reddy GM; Bhaskar BV; Reddy PP; Ashok S; Sudhakar P; Babu JM; Vyas K; Mukkanti K
J Pharm Biomed Anal; 2007 Oct; 45(2):201-10. PubMed ID: 17629653
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of potential impurities of rabeprazole sodium.
Reddy GM; Bhaskar BV; Reddy PP; Sudhakar P; Babu JM; Vyas K; Reddy PR; Mukkanti K
J Pharm Biomed Anal; 2007 Mar; 43(4):1262-9. PubMed ID: 17134865
[TBL] [Abstract][Full Text] [Related]
3. Identification and synthesis of potential impurities of rabeprazole sodium.
Pingili RR; Jambula MR; Ganta MR; Ghanta MR; Sajja E; Sundaram V; Boluggdu VB
Pharmazie; 2005 Nov; 60(11):814-8. PubMed ID: 16320941
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of potential impurities of donepezil.
Krishna Reddy KV; Moses Babu J; Kumar PA; Chandrashekar ER; Mathad VT; Eswaraiah S; Reddy MS; Vyas K
J Pharm Biomed Anal; 2004 Sep; 35(5):1047-58. PubMed ID: 15336352
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of potential impurities of amlodipine maleate.
Sudhakar P; Nirmala M; Moses Babu J; Vyas K; Madhusudan Reddy G; Vijaya Bhaskar B; Pratap Reddy P; Mukkanti K
J Pharm Biomed Anal; 2006 Feb; 40(3):605-13. PubMed ID: 16324814
[TBL] [Abstract][Full Text] [Related]
6. Identification, isolation and characterization of new impurity in rabeprazole sodium.
Rao PS; Ray UK; Gupta PB; Rao DV; Islam A; Rajput P; Mukkanti K
J Pharm Biomed Anal; 2010 Aug; 52(4):620-4. PubMed ID: 20153594
[TBL] [Abstract][Full Text] [Related]
7. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
[TBL] [Abstract][Full Text] [Related]
8. Identification of degradation products in stressed tablets of Rabeprazole sodium by HPLC-hyphenated techniques.
Vasu Dev R; Sai Uday Kiran G; Venkata Subbaiah B; Suresh Babu B; Moses Babu J; Dubey PK; Vyas K
Magn Reson Chem; 2009 May; 47(5):443-8. PubMed ID: 19173350
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB
J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602
[TBL] [Abstract][Full Text] [Related]
10. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium.
Saravanan M; Siva Kumari K; Pratap Reddy P; Naidu MN; Moses Babu J; Srivastava AK; Lakshmi Kumar T; Chandra Sekhar BV; Satyanarayana B
J Pharm Biomed Anal; 2008 Nov; 48(3):708-15. PubMed ID: 18755563
[TBL] [Abstract][Full Text] [Related]
11. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.
Bharathi Ch; Prabahar KJ; Prasad ChS; Srinivasa Rao M; Trinadhachary GN; Handa VK; Dandala R; Naidu A
Pharmazie; 2008 Jan; 63(1):14-9. PubMed ID: 18271296
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist.
Sampath A; Reddy AR; Yakambaram B; Thirupathi A; Prabhakar M; Reddy PP; Reddy VP
J Pharm Biomed Anal; 2009 Oct; 50(3):405-12. PubMed ID: 19560892
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a principal oxidation impurity in clopidogrel drug substance and drug product.
Mohan A; Hariharan M; Vikraman E; Subbaiah G; Venkataraman BR; Saravanan D
J Pharm Biomed Anal; 2008 May; 47(1):183-9. PubMed ID: 18313249
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of new impurity in didanosine.
Srinivasa Rao DV; Srinivas N; Bharathi Ch; Prasad ChS; Dandala R; Naidu A
J Pharm Biomed Anal; 2007 Nov; 45(3):516-20. PubMed ID: 17624711
[TBL] [Abstract][Full Text] [Related]
15. Structural identification and characterization of impurities in ceftizoxime sodium.
Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A
J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586
[TBL] [Abstract][Full Text] [Related]
16. Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR.
Raman B; Sharma BA; Mahale G; Singh D; Kumar A
J Pharm Biomed Anal; 2011 Sep; 56(2):256-63. PubMed ID: 21664089
[TBL] [Abstract][Full Text] [Related]
17. Identification, isolation and characterization of process related impurities in ezetimibe.
Guntupalli S; Ray UK; Murali N; Gupta PB; Kumar VJ; Satheesh D; Islam A
J Pharm Biomed Anal; 2014 Jan; 88():385-90. PubMed ID: 24176742
[TBL] [Abstract][Full Text] [Related]
18. Structural identification and characterization of impurities in moxifloxacin.
Kumar YR; Prasad Raju VV; Kumar RR; Eswaraiah S; Mukkanti K; Suryanarayana MV; Reddy MS
J Pharm Biomed Anal; 2004 Mar; 34(5):1125-9. PubMed ID: 15019047
[TBL] [Abstract][Full Text] [Related]
19. Identification, characterization and synthesis of impurities of zafirlukast.
Goverdhan G; Reddy AR; Srinivas K; Himabindu V; Reddy GM
J Pharm Biomed Anal; 2009 May; 49(4):895-900. PubMed ID: 19231127
[TBL] [Abstract][Full Text] [Related]
20. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.
Raj TJ; Bharathi Ch; Kumar MS; Prabahar J; Kumar PN; Sharma HK; Parikh K
J Pharm Biomed Anal; 2009 Jan; 49(1):156-62. PubMed ID: 19056198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
